ACB Jan 2025 3.500 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

1.8000

0.0000

(0.00%)

As of 12:44PM EDT. Market open.

Loading interactive chart…

Simply Wall St.
Aurora Cannabis Full Year 2024 Earnings: CA$1.28 loss per share (vs CA$8.22 loss in FY 2023)
Aurora Cannabis ( TSE:ACB ) Full Year 2024 Results Key Financial Results Revenue: CA$270.3m (up 16% from FY 2023). Net...
Zacks
Aurora Cannabis Inc. (ACB) Surpasses Q4 Earnings Estimates
Aurora Cannabis (ACB) delivered earnings and revenue surprises of 161.11% and 2.54%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
PR Newswire
Aurora Cannabis Files Full Year Results and Announces Fiscal 2024 Fourth Quarter
Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the fourth quarter and fiscal year 2024. As the fiscal year 2023 consisted of three quarters, the year-over-year comparison quarter for Q4 2024 ending March 31, 2024 is Q3 2023 ending March 31, 2023.